The Dana-Farber Cancer Institute (DFCI) announced in 2024 during its inaugural October 15th Lobular Breast Cancer Awareness Day celebration in Boston, MA, a new Lobular […]
New Lobular Breast Cancer Research Program at Dana-Farber Cancer Institute Read More »
In Case You Missed It: A Comprehensive Overview of Lobular Breast Cancer from the leaders of the new Memorial Sloan Kettering lobular breast cancer programÂ
Watch the Comprehensive Overview of Lobular Breast Cancer from Memorial Sloan Kettering Read More »
https://youtu.be/mCQzS86wMSU Hear from Dr. Manisha Bahl about her award winning lobular study proposal, “Improving Detection of ILC on Digital Breast Tomosynthesis and Reducing False-Negative Rates
Hear from Dr. Higineo (Jose) Dopeso, Senior Research Scientist with Memorial Sloan Kettering, speaking about his winning ILC research grant application, “Deciphering Molecular Mechanisms and
This year Memorial Sloan Kettering launched a new Lobular Breast Cancer Program! This new program focusing on improving treatment for patients with lobular breast cancer
As part of the first Global Lobular Breast Cancer Awareness Day this past October 15th, LBCA collected video reels of patients and families who shared
ILC Stories – Patients and Families Share their Stories in Video Reels Read More »
LBCA SAB Member Dr. Rita Mukhtar, Associate Professor of Clinical Surgery and Associate Program Director, General Surgery at the University of California, San Francisco, shared her
Advocate Chat with Dr. Rita Mukhtar Read More »
As part of Breast Cancer Awareness month, LBCA is shining a spotlight on the 15% of breast cancer diagnoses each year that are invasive lobular
The American Association for Cancer Research (AACR) Interviews Julia Katherine Levine About Her Journey Living with Metastatic Lobular Breast Cancer LBCA founding member and Lead
Recently, LBCA Executive Director Laurie Hutcheson interviewed two recipients of the AACR-Lobular Breast Cancer Alliance – Deborah Mueller Foundation Invasive Lobular Carcinoma Innovation and Discovery Grants.
Hear From LBCA’s New Research Grantees About Their Winning Studies Read More »
LBCA Executive Director, Laurie Hutcheson interviewed our newest Scientific Advisory Board (SAB) member, Dr. Mothaffar Rimawi, to talk about his work in breast cancer research.
Get to Know LBCA’s Newest Scientific Advisory Board (SAB) member, Dr. Rimawi Read More »
LBCA has launched its second Local Advocacy Team, or LAT, for patients with ILC, in Washington, D.C., Maryland & Virginia. LBCA’s Local Advocacy Team Coordinator
Hear About Latest LBCA Local Advocacy Team Activities Read More »
On June 17th, LBCA hosted a webinar, Lobular Breast Cancer Chat: Biomarkers as tools in ILC. In this 45-minute presentation, LBCA Scientific Advisory Board member
LBCA Lobular Breast Cancer Chat: Biomarkers as Tools in ILC Read More »
LBCA’s Lead Research Advocate and Publications/Clinical Trials Curator,  Patient Advocate Advisory Board member and founding member of the Alliance,  Julia Levine, recently interviewed our new Scientific Advisory
Interview with New SAB Board Member, Dr. Rebecca Shatsky Read More »
In February 2022, United States President Joseph Biden reignited the Cancer Moonshot with renewed White House leadership and new ambitious goals: to reduce the death
LBCA Promotes Issues on ILC and Imaging in President’s Cancer Moonshot Program Read More »
"*" indicates required fields